TMRW

TMRW Life Sciences, which operates under the brand TMRW, specializes in at-home health screening to provide individuals with detailed insights into their current and future health. The company's primary offering involves at-home blood tests combined with a digital platform that analyzes results and delivers personalized, actionable health plans. Users can track over 50 biomarkers from a small blood sample, covering areas such as hormone levels, metabolic function, and organ health. The service is designed for individuals who want to proactively manage their health, identify potential risks early, and receive guidance on lifestyle, diet, and supplement changes.

Founded in 2022 by Laurent Uboldi and Pauline Sarg, TMRW aims to shift healthcare from a reactive to a proactive model. Uboldi, who serves as CEO, previously co-founded a digital marketplace. Sarg's background includes experience in venture capital and brand building. The company's business model is direct-to-consumer, with revenue generated from the sale of individual test kits and subscription plans that offer regular testing and ongoing health monitoring. The process involves ordering a kit online, collecting a finger-prick blood sample at home, and sending it to a certified lab for analysis. Results are then delivered through the TMRW dashboard with clear explanations and personalized recommendations.

The platform provides context for the biodata, helping users understand what their results mean in relation to their personal health goals and lifestyle. TMRW positions itself as a tool for preventative health and longevity, empowering users to take control of their well-being by understanding their bodies from the inside out.

Keywords: health screening, at-home testing, blood analysis, preventative healthcare, biomarker tracking, personalized health, direct-to-consumer healthcare, longevity, wellness monitoring, digital health